Adenoid Cystic Carcinoma of the head and neck

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.

Treat

Full Member
7+ Year Member
Joined
Sep 21, 2015
Messages
33
Reaction score
0
For adjuvant treatment of a non-parotid primary site , would you always trace the nearby cranial nerve to the skull base?
Even if there was no gross or microscopic perineural invasion?

Members don't see this ad.
 
Members don't see this ad :)
Hate to break the consensus, but I would ALWAYS trace the cranial nerve to BOS for H&N Adenoid CCa. About 10-15 other RadOnc attendings that I know see H&N cancer would as well (East Coast major metro area).
Are there data on recurrence patterns to support that? Doubt.
 
I always thought it had to involve a "named nerve" with careful review of the path report and discussion with the surgeon.
 
That is correct for squamous cell cancer. Adenoid CCa is believed to be a uniquely neurotropic malignancy.

I always thought it had to involve a "named nerve" with careful review of the path report and discussion with the surgeon.
 
That is correct for squamous cell cancer. Adenoid CCa is believed to be a uniquely neurotropic malignancy.
Yup, also hematogenous, they can often develop lung/bone mets too. They generally don't have lymph node spread. Very different behavior as a whole vs traditional SCC (although really bad SCCs/bulky N3s met out to the lungs too.)
 
I generally trace ACC to the base of skull only if a named nerve is involved. ACC's tend to recur locally quite a bit, though I've seen 1 or 2 lung met cases.
 
isn't cylindroma notorious for spreading along nerve tracts microscopically, often much farther than the path may appear?
 
Yup, also hematogenous, they can often develop lung/bone mets too. They generally don't have lymph node spread. Very different behavior as a whole vs traditional SCC (although really bad SCCs/bulky N3s met out to the lungs too.)

http://www.ncbi.nlm.nih.gov/pubmed/25060927

This study somewhat challenges this paradigm - there may be a role for elective nodal based on these numbers
 
As always, all replies are much appreciated.

For those who replied no to my initial question, what if i flipped the question around - would you only treat if there was nerve involvement? What if there are risk factors eg large primary tumour?
 
For adenoid cystic, I most often (and definitely would with just path PNI, even if not a named nerve) use an SIB plan and treat the operative bed/preop tumor area to 60 Gy @ 2 Gy/fraction and chase the nerve back to the skull base at 1.7 Gy/fraction (51 Gy). I don't usually treat elective lymph nodes.

I answered this way and contoured as such on a boards case and my examiner seemed very pleased with this plan, for whatever that's worth.

With that said, if there was absolutely no PNI noted on path, I don't think it's "wrong" to just treat the operative bed. I would take into account tumor size, margins, co morbidities, etc and make the call then. I feel more strongly about covering back to skull base with PNI, so kind of wishy-washy without it.
 
Top